Qisda (佳世達) reported consolidated growth across all divisions in December 2025, with high-value segments—Network, Medical, and Smart Solutions—outperforming the same period last year.

• AI Infrastructure: The Smart Solutions group is expanding its AI server team to develop customized edge computing products. Key subsidiary Alpha Networks (明泰) is developing 1.6Tbps switches to meet high-speed AI data demands.
• Medical Strategy: Qisda is evolving from a "Smart Hospital" provider to an AI-driven health management platform, starting in Asia with plans for Western expansion.
• Strategic Investment: Qisda recently made a strategic investment in AM BioTech (陞醫生技), a specialist in bio-pulsed exosomes for medical aesthetics. AM BioTech plans a public offering in 2026 and an IPO in 2027.
• Outlook: Following 2025 as an operational trough, Qisda’s 2026 objective is "Profit Improvement" through enhanced management and synergy.

Resource: 佳世達拚高附加價值事業，AI/醫療/智能方案齊發